DAVID A RAMSAY
CIK 1283292 · Interim CFO · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.33M
Companies
5
Total Filings
76
Lifetime Open-Market Net
$4.25M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTI | Interim CFO | 364,320 | — | — | -$33.8K | 19 | 2026-04-02 |
| SVRA | Director | 2,533,642 | $5.26 | $13.33M | $3.85M | 39 | 2025-12-19 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Director | 97,000 | $6.22 | $603.3K | $384.8K | 9 | 2022-01-14 |
| MSTX | Director | — | $16.18 | — | $0 | 4 | 2017-01-23 |
| Savara Inc (ANX) Delisted | Director | 100,000 | — | — | $55.1K | 4 | 2012-07-30 |
Recent Filings · Page 4 of 8
76 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-22 | SVRA | Buy (P) | +200,000 | $215.4K | EDGAR |
| 2021-11-19 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +7,500 | $31.7K | EDGAR |
| 2021-09-30 | SVRA | Buy (P) | +137,052 | $176.4K | EDGAR |
| 2021-08-19 | SVRA | Buy (P) | +97,290 | $115.2K | EDGAR |
| 2021-05-26 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +20,000 | $69.8K | EDGAR |
| 2021-05-20 | SVRA | Buy (P) | +5,003 | $7.9K | EDGAR |
| 2021-05-18 | SVRA | Buy (P) | +50,000 | $81.1K | EDGAR |
| 2021-03-15 | SVRA | Buy (P) | +689,655 | $1000.0K | EDGAR |
| 2020-12-17 | SVRA | Grant (A) | — | $0 | EDGAR |
| 2020-12-14 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.